British journal of cancer
High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD).
Visalini Nair-Shalliker, David P Smith, Val Gebski, Manish I Patel, Mark Frydenberg, John Yaxley, Robert 'Frank' Gardiner, David Espinoza, Michael G Kimlin, Varinderpal Dhillon, Wayne Leifert, David Gillatt, Henry Woo, Krishan Rasiah, Nader Awad
Published: 202510.1038/s41416-025-03278-w
Abstract
BACKGROUND: The ProsD trial aimed to determine if oral vitamin D supplementation could prevent prostate cancer (PC) progression in men on active surveillance (AS). METHODS: ProsD is a phase-II double-blinded randomized trial of newly diagnosed, low-i…
Preview only. Read the full abstract at the source